Semaglutide and tirzepatide are prescription medicines used in certain FDA-approved products. Wegovy and Zepbound are examples of products approved for chronic weight management in eligible patients. A clinician can assess eligibility based on the product labeling and your health history.
FDA-approved and compounded products
Compounded products do not go through FDA premarket review for safety, quality or effectiveness. The FDA declared the injection shortages for semaglutide and tirzepatide resolved. Compounding copies after a shortage ends is subject to restrictions. Ask what patient-specific need a compounded product would address and who would dispense it.
What to discuss with your clinician
Ask about expected benefits, nausea or other digestive effects, important warnings and any interactions with medicines you take. Get a plan for follow-up and ask what happens if treatment is interrupted.
Compare the full cost
Check medication, visits, labs, shipping and refill costs. Ask whether advertised monthly prices require upfront payment and whether your insurance covers the specific product and indication.